Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015 (2015), Article ID 408935, 11 pages
http://dx.doi.org/10.1155/2015/408935
Research Article

Free DNA in Cystic Fibrosis Airway Fluids Correlates with Airflow Obstruction

1Department of Pediatric Pulmonology, Hauner Children’s Hospital, Ludwig Maximilians University, The German Center for Lung Research (DZL), 80377 Munich, Germany
2Department of Translational Pulmonology, Translational Lung Research Center Heidelberg (TLRC), University of Heidelberg, The German Center for Lung Research (DZL), 69120 Heidelberg, Germany
3Comprehensive Pneumology Center, Institute of Lung Biology and Disease (iLBD), University Hospital, Ludwig Maximilians University and Helmholtz Zentrum München, The German Center for Lung Research (DZL), 81377 Munich, Germany
4Children’s Hospital and Interdisciplinary Center for Infectious Diseases, University of Tübingen, 72076 Tübingen, Germany
5Department of Operative Dentistry & Periodontology, Saarland University, 66424 Homburg, Germany
6Biomedical Ultrastructure Research Lab, Division of Animal Structure and Function, Department of Cell Biology, University of Salzburg, 5020 Salzburg, Austria

Received 11 January 2015; Revised 11 March 2015; Accepted 13 March 2015

Academic Editor: Pham My-Chan Dang

Copyright © 2015 Veronica Marcos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. A. Mall and D. Hartl, “CFTR: cystic fibrosis and beyond,” European Respiratory Journal, vol. 44, no. 4, pp. 1042–1054, 2014. View at Publisher · View at Google Scholar
  2. E. Fantino, C. L. Gangell, D. Hartl, P. D. Sly, and C. F. Arest, “Airway, but not serum or urinary, levels of YKL-40 reflect inflammation in early cystic fibrosis lung disease,” BMC Pulmonary Medicine, vol. 14, article 28, 2014. View at Publisher · View at Google Scholar
  3. P. D. Sly, C. L. Gangell, L. Chen et al., “Risk factors for bronchiectasis in children with cystic fibrosis,” The New England Journal of Medicine, vol. 368, no. 21, pp. 1963–1970, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Hartl, A. Gaggar, E. Bruscia et al., “Innate immunity in cystic fibrosis lung disease,” Journal of Cystic Fibrosis, vol. 11, no. 5, pp. 363–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. S. D. Sagel, M. K. Sontag, J. S. Wagener, R. K. Kapsner, I. Osberg, and F. J. Accurso, “Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis,” Journal of Pediatrics, vol. 141, no. 6, pp. 811–817, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. D. Sagel, R. Kapsner, I. Osberg, M. K. Sontag, and F. J. Accurso, “Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction,” The American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 8 I, pp. 1425–1431, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Hector, M. S. D. Kormann, I. Mack et al., “The chitinase-like protein YKL-40 modulates cystic fibrosis lung disease,” PLoS ONE, vol. 6, no. 9, Article ID e24399, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Gehrig, J. Duerr, M. Weitnauer et al., “Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosislike lung disease,” American Journal of Respiratory and Critical Care Medicine, vol. 189, no. 9, pp. 1082–1092, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Kirchner, J. S. Wagener, T. Z. Khan, S. C. Copenhaver, and F. J. Accurso, “Increased DNA levels in bronchoalveolar lavage fluid obtained from infants with cystic fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 154, no. 5, pp. 1426–1429, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Papayannopoulos, D. Staab, and A. Zychlinsky, “Neutrophil elastase enhances sputum solubilization in cystic fibrosis patients receiving dnase therapy,” PLoS ONE, vol. 6, no. 12, Article ID e28526, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. R. L. Young, K. C. Malcolm, J. E. Kret et al., “Neutrophil extracellular trap (NET)-mediated killing of pseudomonas aeruginosa: evidence of acquired resistance within the CF airway, independent of CFTR,” PLoS ONE, vol. 6, no. 9, Article ID e23637, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Dwyer, Q. Shan, S. D'Ortona et al., “Cystic fibrosis sputum DNA Has NETosis characteristics and neutrophil extracellular trap release is regulated by macrophage migration-inhibitory factor,” Journal of Innate Immunity, vol. 6, no. 6, pp. 765–779, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. D.-G. Yoo, M. Floyd, M. Winn, S. M. Moskowitz, and B. Rada, “NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes,” Immunology Letters, vol. 160, no. 2, pp. 186–194, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Manzenreiter, F. Kienberger, V. Marcos et al., “Ultrastructural characterization of cystic fibrosis sputum using atomic force and scanning electron microscopy,” Journal of Cystic Fibrosis, vol. 11, no. 2, pp. 84–92, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. V. Brinkmann, U. Reichard, C. Goosmann et al., “Neutrophil extracellular traps kill bacteria,” Science, vol. 303, no. 5663, pp. 1532–1535, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Brinkmann and A. Zychlinsky, “Beneficial suicide: why neutrophils die to make NETs,” Nature Reviews Microbiology, vol. 5, no. 8, pp. 577–582, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. T. A. Fuchs, U. Abed, C. Goosmann et al., “Novel cell death program leads to neutrophil extracellular traps,” The Journal of Cell Biology, vol. 176, no. 2, pp. 231–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Yousefi, J. A. Gold, N. Andina et al., “Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense,” Nature Medicine, vol. 14, no. 9, pp. 949–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Yousefi, D. Simon, and H.-U. Simon, “Eosinophil extracellular DNA traps: molecular mechanisms and potential roles in disease,” Current Opinion in Immunology, vol. 24, no. 6, pp. 736–737, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Yousefi, C. Mihalache, E. Kozlowski, I. Schmid, and H. U. Simon, “Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps,” Cell Death & Differentiation, vol. 16, no. 11, pp. 1438–1444, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Simon, H.-U. Simon, and S. Yousefi, “Extracellular DNA traps in allergic, infectious, and autoimmune diseases,” Allergy, vol. 68, no. 4, pp. 409–416, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Morshed, R. Hlushchuk, D. Simon et al., “NADPH oxidase-independent formation of extracellular DNA traps by basophils,” The Journal of Immunology, vol. 192, no. 11, pp. 5314–5323, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Dworski, H.-U. Simon, A. Hoskins, and S. Yousefi, “Eosinophil and neutrophil extracellular DNA traps in human allergic asthmatic airways,” Journal of Allergy and Clinical Immunology, vol. 127, no. 5, pp. 1260–1266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Peschel and D. Hartl, “Anuclear neutrophils keep hunting,” Nature Medicine, vol. 18, no. 9, pp. 1336–1338, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. G. Yipp, B. Petri, D. Salina et al., “Dynamic NETosis is carried out by live neutrophils in human and mouse bacterial abscesses and during severe gram-positive infection,” Nature Medicine, vol. 6, no. 20, 2012. View at Google Scholar
  26. M. Mall, B. R. Grubb, J. R. Harkema, W. K. O'Neal, and R. C. Boucher, “Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice,” Nature Medicine, vol. 10, no. 5, pp. 487–493, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Z. Zhou, J. Duerr, B. Johannesson et al., “The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease,” Journal of Cystic Fibrosis, vol. 10, supplement 2, pp. S172–S182, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Mall, S. Y. Graeber, M. Stahl, and Z. Zhou-Suckow, “Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice,” The International Journal of Biochemistry & Cell Biology, vol. 52, pp. 174–179, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. A. Mall, J. R. Harkema, J. B. Trojanek et al., “Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice,” The American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 7, pp. 730–742, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. T. W. R. Lee, K. G. Brownlee, S. P. Conway, M. Denton, and J. M. Littlewood, “Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients,” Journal of Cystic Fibrosis, vol. 2, no. 1, pp. 29–34, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Hartl, V. Starosta, K. Maier et al., “Inhaled glutathione decreases PGE2 and increases lymphocytes in cystic fibrosis lungs,” Free Radical Biology and Medicine, vol. 39, no. 4, pp. 463–472, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Hartl, P. Latzin, P. Hordijk et al., “Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease,” Nature Medicine, vol. 13, no. 12, pp. 1423–1430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. A. J. Vanoirbeek, M. Rinaldi, V. De Vooght et al., “Noninvasive and invasive pulmonary function in mouse models of obstructive and restrictive respiratory diseases,” The American Journal of Respiratory Cell and Molecular Biology, vol. 42, no. 1, pp. 96–104, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. A. Mall, B. Button, B. Johannesson et al., “Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with βENaC-overexpressing mice,” Journal of Biological Chemistry, vol. 285, no. 35, pp. 26945–26955, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Saffarzadeh, C. Juenemann, M. A. Queisser et al., “Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones,” PLoS ONE, vol. 7, no. 2, Article ID e32366, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. V. Papayannopoulos and A. Zychlinsky, “NETs: a new strategy for using old weapons,” Trends in Immunology, vol. 30, no. 11, pp. 513–521, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Zychlinsky, “Neutrophil extracellular traps,” European Journal of Clinical Investigation, vol. 39, p. 27, 2009. View at Google Scholar
  38. M. Zawrotniak and M. Rapala-Kozik, “Neutrophil extracellular traps (NETs)—formation and implications,” Acta Biochimica Polonica, vol. 60, no. 3, pp. 277–284, 2013. View at Google Scholar · View at Scopus
  39. B. G. Yipp and P. Kubes, “NETosis: how vital is it?” Blood, vol. 122, no. 16, pp. 2784–2794, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. O. Z. Cheng and N. Palaniyar, “NET balancing: a problem in inflammatory lung diseases,” Frontiers in Immunology, vol. 4, article 1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. A. Fuchs, A. Brill, and D. D. Wagner, “Neutrophil extracellular trap (NET) impact on deep vein thrombosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 8, pp. 1777–1783, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. M.-L. von Brühl, K. Stark, A. Steinhart et al., “Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo,” Journal of Experimental Medicine, vol. 209, no. 4, pp. 819–835, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. S. Rahman and M. Gadjeva, “Does NETosis contribute to the bacterial pathoadaptation in cystic fibrosis?” Frontiers in Immunology, vol. 5, article 378, 2014. View at Publisher · View at Google Scholar
  44. P. A. Flume, B. P. O'Sullivan, K. A. Robinson et al., “Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 10, pp. 957–969, 2007. View at Publisher · View at Google Scholar
  45. G. Döring, P. Flume, H. Heijerman, and J. S. Elborn, “Treatment of lung infection in patients with cystic fibrosis: current and future strategies,” Journal of Cystic Fibrosis, vol. 11, no. 6, pp. 461–479, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. A. Flume and D. R. van Devanter, “State of progress in treating cystic fibrosis respiratory disease,” BMC Medicine, vol. 10, article 88, 2012. View at Publisher · View at Google Scholar · View at Scopus
  47. Q. Shan, M. Dwyer, S. Rahman, and M. Gadjeva, “Distinct susceptibilities of corneal Pseudomonas aeruginosa clinical isolates to neutrophil extracellular trap-mediated immunity,” Infection and Immunity, vol. 82, no. 10, pp. 4135–4143, 2014. View at Publisher · View at Google Scholar
  48. D. G. Yoo, M. Winn, L. Pang et al., “Release of cystic fibrosis airway inflammatory markers from pseudomonas aeruginosa-stimulated human neutrophils involves NADPH oxidase-dependent extracellular DNA trap formation,” Journal of Immunology, vol. 192, no. 10, pp. 4728–4738, 2014. View at Publisher · View at Google Scholar · View at Scopus
  49. B. Rada, M. A. Jendrysik, L. Pang et al., “Pyocyanin-enhanced neutrophil extracellular trap formation requires the NADPH oxidase,” PLoS ONE, vol. 8, no. 1, Article ID e54205, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. N. Branzk, A. Lubojemska, S. E. Hardison et al., “Neutrophils sense microbe size and selectively release neutrophil extracellular traps in response to large pathogens,” Nature Immunology, vol. 15, no. 11, pp. 1017–1025, 2014. View at Publisher · View at Google Scholar
  51. O. E. Sørensen, S. N. Clemmensen, S. L. Dahl et al., “Papillon-Lefèvre syndrome patient reveals species-dependent requirements for neutrophil defenses,” The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4539–4548, 2014. View at Publisher · View at Google Scholar
  52. K. D. Metzler, C. Goosmann, A. Lubojemska, A. Zychlinsky, and V. Papayannopoulos, “A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis,” Cell Reports, vol. 8, no. 3, pp. 883–896, 2014. View at Publisher · View at Google Scholar
  53. N. Branzk and V. Papayannopoulos, “Molecular mechanisms regulating NETosis in infection and disease,” Seminars in Immunopathology, vol. 35, no. 4, pp. 513–530, 2013. View at Publisher · View at Google Scholar · View at Scopus
  54. V. Papayannopoulos, K. D. Metzler, A. Hakkim, and A. Zychlinsky, “Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps,” The Journal of Cell Biology, vol. 191, no. 3, pp. 677–691, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. A. V. Dubois, A. Gauthier, D. Bréa et al., “Influence of DNA on the activities and inhibition of neutrophil serine proteases in cystic fibrosis sputum,” American Journal of Respiratory Cell and Molecular Biology, vol. 47, no. 1, pp. 80–86, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Griese, M. Kappler, A. Gaggar, and D. Hartl, “Inhibition of airway proteases in cystic fibrosis lung disease,” European Respiratory Journal, vol. 32, no. 3, pp. 783–795, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. F. Carswell, D. W. Robinson, C. C. L. Ward, and M. R. Waterfield, “Deoxyribonucleic acid output in the sputum from cystic fibrosis patients,” European Journal of Respiratory Diseases, vol. 65, no. 1, pp. 53–57, 1984. View at Google Scholar · View at Scopus
  58. J.-S. Kim, K. Okamoto, and B. K. Rubin, “Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis,” Chest, vol. 129, no. 5, pp. 1148–1154, 2006. View at Publisher · View at Google Scholar · View at Scopus
  59. D. N. Douda, R. Jackson, H. Grasemann, and N. Palaniyar, “Innate immune collectin surfactant protein D simultaneously binds both neutrophil extracellular traps and carbohydrate ligands and promotes bacterial trapping,” The Journal of Immunology, vol. 187, no. 4, pp. 1856–1865, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. P. E. Bratcher, N. M. Weathington, H. J. Nick, P. L. Jackson, R. J. Snelgrove, and A. Gaggar, “MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro,” PLoS ONE, vol. 7, no. 7, Article ID e41881, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. H. V. Olesen, U. Holmskov, P. O. Schiøtz, and G. L. Sørensen, “Serum-surfactant SP-D correlates inversely to lung function in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 9, no. 4, pp. 257–262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. J. Cooley, B. McDonald, F. J. Accurso, E. C. Crouch, and E. Remold-O'Donnell, “Patterns of neutrophil serine protease-dependent cleavage of surfactant protein D in inflammatory lung disease,” Journal of Leukocyte Biology, vol. 83, no. 4, pp. 946–955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Hartl and M. Griese, “Surfactant protein D in human lung diseases,” European Journal of Clinical Investigation, vol. 36, no. 6, pp. 423–435, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. C. von Bredow, A. Wiesener, and M. Griese, “Proteolysis of surfactant protein D by cystic fibrosis relevant proteases,” Lung, vol. 181, no. 2, pp. 79–88, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. F. H. Pilsczek, D. Salina, K. K. H. Poon et al., “A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus,” Journal of Immunology, vol. 185, no. 12, pp. 7413–7425, 2010. View at Publisher · View at Google Scholar · View at Scopus
  66. M. Saffarzadeh and K. T. Preissner, “Fighting against the dark side of neutrophil extracellular traps in disease: manoeuvres for host protection,” Current Opinion in Hematology, vol. 20, no. 1, pp. 3–9, 2013. View at Publisher · View at Google Scholar · View at Scopus